Neoleukin Therapeutics

+$0.02 (+0.16%) Today
$0.00 (0.00%) As of 8:00 PM UTC after-hours

Why Robinhood?

You can buy or sell NLTX and other stocks, options, and ETFs commission-free!

About NLTX

Neoleukin Therapeutics, Inc. operates as a biopharmaceutical company, which computational methods to design de novo protein therapeutics. The firm address significant medical needs in oncology, inflammation, and autoimmunity.

CEO
Jonathan G. Drachman
Employees
70
Headquarters
Seattle, Washington
Founded
2003
Market Cap
519.25M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
154.36K
High Today
$12.85
Low Today
$12.21
Open Price
$12.38
Volume
251.09K
52 Week High
$18.13
52 Week Low
$9.63

NLTX Earnings

-$0.44
-$0.29
-$0.15
$0.00
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Estimated
— per share
Actual
Expected May 6, After Hours

You May Also Like

OPA=
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure